Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss: XIENCE 90/28: Assessment of Three-Month and One-Month DAPT After Everolimus-Eluting Stents in High-Bleeding Risk Patients
Loading…
Disclosures: TBD
Clinical Trial Results
Disclosures: TBD